Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Social media

Han Leng Ng

Postdoctoral Researcher

Current research

Across each generation, an offspring acquires ~30-90 de novo mutations (DNMs) in their genome. These mutations are absent in the somatic cells of the parents, but are present in the parents germ cells. It is now understood that the male germ cells contribute to ~80% of DNMs found in his offspring. The number of inherited DNMs increases linearly with the age of the father. However, a class of DNMs exists that does not follow this linear correlation, which is termed as 'selfish' mutations.

'Selfish' mutations provide mutant spermatogonial stem cells with a selective advantage over neighbouring healthy cells. Over time, there is an accumulation of mutant sperm, with an increased risk of transmission to their offspring, known as 'paternal age effect' disorders.

I am interested in using next-generation sequencing technology to identify novel rare 'selfish' mutations.

Background

I graduated from the University of Western Australia with a Bachelor of Sciences in molecular biology. Following which, I obtained a Bachelor of Science with Honours in genetics, before pursuing a PhD. I completed my PhD in 2019 with Professor Daniela Ulgiati, at the University of Western Australia, where I investigated the role of Notch signalling in regulating the expression of Complement Receptor 2 (CR2/CD21) during B-cell development. In 2020, I joined the lab of Dr Niklas Feldhahn at Imperial College London as a postdoctoral researcher. During my time there (2020-2023), I investigated the transcriptional landscape changes of BCR::ABL1+ B-cell acute lymphoblastic leukaemia. My research involved using several high-throughput techniques, including promoter-capture Hi-C, ChIP-seq and RNA-seq,